Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 78

Sort by

Sort Order Select

Journal Articles

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML)

Blood (2016) 128 (22): 4065.

https://doi.org/10.1182/blood.V128.22.4065.4065

Published: 2016

Journal Articles

Phenotype/Genotype Associations in TET2-Driven Myeloid Neoplasms

Cassandra M. Hirsch, BSc, Aziz Nazha, MD, Kassy E Kneen, Bartlomiej P Przychodzen, MSc, Niroshan Nadarajah, M.Sc., Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Torsten Haferlach, MD, Tomas Radivoyevitch, PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Manja Meggendorfer, PhD

Blood (2016) 128 (22): 4313.

https://doi.org/10.1182/blood.V128.22.4313.4313

Published: 2016

Journal Articles

Distinct Clinical and Biological Implications of Various DNTMT3A Mutations in Myeloid Neoplasms

Suresh Kumar Balasubramanian, MD, Mai Ali, Taha Bat, MD, Bhumika Patel, MD, Bartlomiej P Przychodzen, MSc, Cassandra M. Hirsch, BSc, Aziz Nazha, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 2872.

https://doi.org/10.1182/blood.V128.22.2872.2872

Published: 2016

Journal Articles

Subset-Specific Recurrence of Mutations and Identification of Functional Modules Provides New Clues about the Pathogenesis of Large Granular Lymphocyte Leukemia

Alessandro Coppe, BSc, PhD, Emma I Andersson, MSc, Andrea Binatti, BSc, Vanessa R Gasparini, Sabrina Bortoluzzi, Michael J. Clemente, M.S., Marco Herling, MD PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Satu Mustjoki, MD PhD, Stefania Bortoluzzi, BSc, PhD

Blood (2016) 128 (22): 4117.

https://doi.org/10.1182/blood.V128.22.4117.4117

Published: 2016

Journal Articles

the Impact of Clonal Dynamics on Prognosis and Outcome in Myelodysplastic Syndromes

Hideki Makishima, MD PhD FACP., Tetsuichi Yoshizato, MD PhD, Kenichi Yoshida, MD PhD, Mikkael A. Sekeres, MD MS, Tomas Radivoyevitch, PhD, Hiromichi Suzuki, MD PhD, Bartlomiej P Przychodzen, MSc, Yasunobu Nagata, MD, PhD, Manja Meggendorfer, PhD, Masashi Sanada, MD PhD, Yusuke Okuno, MD PhD, Cassandra M. Hirsch, BSc, Teodora Kuzmanovic, Yusuke Shiozawa, MD, Yusuke Sato, MD PhD, Aiko Sato-Otsubo, Thomas LaFramboise, PhD, Naoko Hosono, MD, PhD, Yuichi Shiraishi, PhD, Kenichi Chiba, BA, Claudia Haferlach, MD, Wolfgang Kern, MD, Hiroko Tanaka, BA, Ines Gómez-Seguí, MD PhD, Holleh Husseinzadeh, MD, Swapna Thota, MD, Kathryn M. Guinta, Brittney Dienes, Tsuyoshi Nakamaki, MD, Shuichi Miyawaki, MD PhD, Yogen Saunthararajah, MD, Shigeru Chiba, MD, PhD, Satoru Miyano, PhD, Lee-Yung Shih, MD, Torsten Haferlach, MD, Seishi Ogawa, MD PhD, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 4287.

https://doi.org/10.1182/blood.V128.22.4287.4287

Published: 2016

Journal Articles

Clonal Events of Aplastic Anemia Related to the Evolution to Myelodysplastic Syndrome

Eiju Negoro, MD, PhD, Michael Clemente, M.S., Naoko Hosono, MD,PhD, Aziz Nazha, MD, Wenyi Shen, MD, Yasunobu Nagata, MD, PhD, Cassandra M. Hirsch, BSc, Bartlomiej P Przychodzen, MSc, Reda Z. Mahfouz, MD, PhD, Teodora Kuzmanovic, BSc, Hideki Makishima, MD PhD FACP., Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD, PhD, FACP

Blood (2016) 128 (22): 4290.

https://doi.org/10.1182/blood.V128.22.4290.4290

Published: 2016

Journal Articles

Analysis of Outcomes of Patients with Relapsed/Refractory Acute Myeloid Leukemia Treated in Randomized Clinical Trials

Raffi Tchekmedyian, BS, Paul Elson, PhD, Aaron T. Gerds, MD MS, Navneet Majhail, MD MS, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Aziz Nazha, MD, Jaroslaw P Maciejewski, MD PhD FACP, Matt Kalaycio, MD FACP, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD, PhD, M.P.H.

Blood (2016) 128 (22): 4000.

https://doi.org/10.1182/blood.V128.22.4000.4000

Published: 2016

Journal Articles

BCOR and BCORL1 mutations in Myelodysplastic Syndromes (MDS): Clonal Architecture and Impact on Outcomes

Nour Abuhadra, MD, Karam Al-Issa, MD, Aaron T. Gerds, MD MS, Sudipto Mukherjee, MD, PhD, M.P.H., Bhumika Patel, MD, Michael J. Clemente, M.S., Vera Adema, PhD, Cassandra M. Hirsch, BSc, Anjali S. Advani, MD, Mai Aly, Przychodzen P Bartlomiej, Hetty E. Carraway, MD, Jaroslaw P Maciejewski, MD PhD FACP, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD

Blood (2016) 128 (22): 4293.

https://doi.org/10.1182/blood.V128.22.4293.4293

Published: 2016

Journal Articles

Targeting Autophagy in Myelodysplastic Syndromes

Valeria Visconte, PhD, Steffan T. Nawrocki, PhD, Bartlomiej P Przychodzen, MSc, Kevin R. Kelly, MD PhD, Mei Yin, Yvonne Parker, Michael J. Clemente, M.S., John Barnard, PhD, Anjali S. Advani, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Daniel Lindner, Heesun J Rogers, MD PhD, Jaroslaw P Maciejewski, MD PhD FACP, Jennifer S. Carew, PhD

Blood (2016) 128 (22): 4295.

https://doi.org/10.1182/blood.V128.22.4295.4295

Published: 2016

Journal Articles

Importance of Complete Remission on Predicting Overall Survival in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)

Aziz Nazha, MD, Rami S. Komrokji, MD, John Barnard, PhD, Najla H Al Ali, Gail J. Roboz, David P. Steensma, MD, Amy E. DeZern, MD MHS, Jaime Fensterl, Guillermo Garcia-Manero, MD, Alan F List, MD, Jaroslaw P Maciejewski, MD PhD FACP, Mikkael A. Sekeres, MD MS

Blood (2016) 128 (22): 4332.

https://doi.org/10.1182/blood.V128.22.4332.4332

Published: 2016

Journal Articles

Evolving Risk of Myelodysplastic Syndromes Among Adolescents and Young Adults Following Radiation Treatment for First Cancers in the United States, 1973 - 2014

Remco Molenaar, M.Sc., Tomas Radivoyevitch, PhD, Hetty E. Carraway, MD MBA, Jaroslaw P. Maciejewski, MD, PhD, FACP, Mikkael A Sekeres, MD MS, Sudipto Mukherjee, MD, PhD, M.P.H.

Blood (2016) 128 (22): 4334.

https://doi.org/10.1182/blood.V128.22.4334.4334

Published: 2016

Journal Articles

TP53 Mutations and Outcome in Patients with Myelodysplastic Syndromes (MDS)

Karam Al-Issa, MD, Mikkael A. Sekeres, MD MS, Alek d Nielsen, B.S., Babal Jha, PhD, Bartlomiej P Przychodzen, MSc, Mai Aly, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Bhumika Patel, MD, Michael J. Clemente, M.S., Sudipto Mukherjee, MD, PhD, M.P.H., Aaron T. Gerds, MD MS, Jaroslaw P Maciejewski, MD PhD FACP, Aziz Nazha, MD

Blood (2016) 128 (22): 4336.

https://doi.org/10.1182/blood.V128.22.4336.4336

Published: 2016

Journal Articles

Genetic and Epigenetic Defects in the Autophagy Machinery in Myelodysplastic Syndromes

Valeria Visconte, PhD, Bartlomiej P Przychodzen, MSc, Steffan T. Nawrocki, PhD, Swapna Thota, MD, Kevin R. Kelly, MD PhD, Bhumika Patel, MD, Cassandra M. Hirsch, BSc, Hetty E. Carraway, MD MBA, Yvonne Parker, Daniel Lindner, Mikkael A. Sekeres, MD MS, Heesun J Rogers, MD PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Jennifer S. Carew, PhD

Blood (2016) 128 (22): 4301.

https://doi.org/10.1182/blood.V128.22.4301.4301

Published: 2016

Journal Articles

A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia Undergoing Remission Induction Therapy

Sudipto Mukherjee, MD, PhD, M.P.H., Paul Elson, PhD, Samjhana Bogati, BSN, Ashley Woltman, BSN, RN, John Desamito, Aaron T. Gerds, MD MS, Hetty E. Carraway, MD MBA, Anjali S. Advani, Yogen Saunthararajah, MD, Jaroslaw P Maciejewski, MD PhD FACP, Matt Kalaycio, MD, Mikkael A. Sekeres, MD MS

Blood (2016) 128 (22): 447.

https://doi.org/10.1182/blood.V128.22.447.447

Published: 2016

Journal Articles

NGS-Based Copy Number Analysis in 1,185 Patients with Myeloid Neoplasms

Blood (2016) 128 (22): 955.

https://doi.org/10.1182/blood.V128.22.955.955

Published: 2016

Journal Articles

Landscape of Subclonal Mutations in Myelodysplastic Syndromes (MDS) Allows for a Novel Hierarchy of Clonal Advantage By Combining Germline and Somatic Mutations

Blood (2016) 128 (22): 957.

https://doi.org/10.1182/blood.V128.22.957.957

Published: 2016

Journal Articles

Is Serial Monitoring of Myeloid Mutations Clinically Relevant in Myelodysplastic Syndromes (MDS): A Report on Behalf of the MDS Clinical Research Consortium (CRC)

Sangmin Lee, MD, John Barnard, PhD, Amy E. DeZern, MD MHS, Jaroslaw P Maciejewski, MD PhD FACP, Najla Alali, MS, David P. Steensma, MD, Ellen K. Ritchie, MD, Pinkal Desai, MD, Guillermo Garcia-Manero, MD, Fatima Ali, B.S., Nicole Rizzo, BA, Duane C Hassane, PhD, Rami S. Komrokji, MD, Mikkael A. Sekeres, MD MS, Gail J. Roboz

Blood (2016) 128 (22): 297.

https://doi.org/10.1182/blood.V128.22.297.297

Published: 2016

Journal Articles

Next-Generation Sequencing Analysis of Clonal Hierarchy and Dynamics in T-Large Granular Lymphocyte Leukemia Suggests Emergence of STAT3 Clones within Pre-Existing Dominant T-Cell Repertoire Responses Otherwise Silenced in Normal Individuals

Peter W Chomczynski, Michael J. Clemente, M.S., Srinivasa Reddy Sanikommu, MD, Alek d Nielsen, B.S., Cassandra M. Hirsch, BSc, Hanna Rajala, MD, Mikkael A. Sekeres, MD MS, Hetty E. Carraway, MD MBA, Satu Mustjoki, MD PhD, Alan E. Lichtin, MD, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 2731.

https://doi.org/10.1182/blood.V128.22.2731.2731

Published: 2016

Journal Articles

PHF6 Somatic Mutations and Their Functional Role in the Pathophysiology of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Bartlomiej P Przychodzen, MSc, Xiaorong Gu, PhD, Dewen You, PhD, Cassandra M. Hirsch, BSc, Michael J. Clemente, M.S., Mikkael A. Sekeres, MD MS, Aziz Nazha, MD, Hideki Makishima, MD PhD FACP., Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 2736.

https://doi.org/10.1182/blood.V128.22.2736.2736

Published: 2016

Journal Articles

Clinical Effects of IDH1/2-Mutant Inhibitors in IDH1/ 2-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients: Suggestions from Ex Vivo Experiments

Remco Molenaar, M.Sc., Tomas Radivoyevitch, PhD, Mohammed Khurshed, MD, Eiju Negoro, MD, PhD, Bartlomiej P Przychodzen, MSc, Hetty E. Carraway, MD MBA, Cornelis J van Noorden, PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP

Blood (2016) 128 (22): 4308.

https://doi.org/10.1182/blood.V128.22.4308.4308

Published: 2016

NARROW

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML)

Phenotype/Genotype Associations in TET2-Driven Myeloid Neoplasms

Distinct Clinical and Biological Implications of Various DNTMT3A Mutations in Myeloid Neoplasms

Subset-Specific Recurrence of Mutations and Identification of Functional Modules Provides New Clues about the Pathogenesis of Large Granular Lymphocyte Leukemia

the Impact of Clonal Dynamics on Prognosis and Outcome in Myelodysplastic Syndromes

Clonal Events of Aplastic Anemia Related to the Evolution to Myelodysplastic Syndrome

Analysis of Outcomes of Patients with Relapsed/Refractory Acute Myeloid Leukemia Treated in Randomized Clinical Trials

BCOR and BCORL1 mutations in Myelodysplastic Syndromes (MDS): Clonal Architecture and Impact on Outcomes

Targeting Autophagy in Myelodysplastic Syndromes

Importance of Complete Remission on Predicting Overall Survival in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)

Evolving Risk of Myelodysplastic Syndromes Among Adolescents and Young Adults Following Radiation Treatment for First Cancers in the United States, 1973 - 2014

TP53 Mutations and Outcome in Patients with Myelodysplastic Syndromes (MDS)

Genetic and Epigenetic Defects in the Autophagy Machinery in Myelodysplastic Syndromes

A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia Undergoing Remission Induction Therapy

NGS-Based Copy Number Analysis in 1,185 Patients with Myeloid Neoplasms

Landscape of Subclonal Mutations in Myelodysplastic Syndromes (MDS) Allows for a Novel Hierarchy of Clonal Advantage By Combining Germline and Somatic Mutations

Is Serial Monitoring of Myeloid Mutations Clinically Relevant in Myelodysplastic Syndromes (MDS): A Report on Behalf of the MDS Clinical Research Consortium (CRC)

Next-Generation Sequencing Analysis of Clonal Hierarchy and Dynamics in T-Large Granular Lymphocyte Leukemia Suggests Emergence of STAT3 Clones within Pre-Existing Dominant T-Cell Repertoire Responses Otherwise Silenced in Normal Individuals

PHF6 Somatic Mutations and Their Functional Role in the Pathophysiology of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Clinical Effects of IDH1/2-Mutant Inhibitors in IDH1/ 2-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients: Suggestions from Ex Vivo Experiments

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only